Teva Pharmaceuticals USA recalls Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARM
Recalled February 1, 2017 · FDA recall D-0440-2017 · Teva Pharmaceuticals USA
Hazard
Subpotency: due to a low, out of specification test result for assay during stability testing. · FDA Class II
Units
133,601 bottles
Sold at
United States and Puerto Rico
Description
Subpotency: due to a low, out of specification test result for assay during stability testing.
Product
Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →